The Bioprocessing Reagent market size is expected to reach $16.06 billion by 2030 at a CAGR of 12.3%, driven by rising demand for monoclonal antibody and biologics production.
Read More
The global Alirocumab market size is expected to reach $3.48 billion in 2030 at a CAGR of 10.6%, driven by increasing prevalence of cardiovascular diseases.
Read More
The Advanced Lab Reagents market size is expected to reach $2.92 billion in 2030 at a CAGR of 11.8%, driven by increasing prevalence of chronic diseases.
Read More
The Acetaminophen market size is expected to reach $11.79 billion in 2030 at a CAGR of 5.1%, driven by rising fever cases and growing OTC medication demand.
Read More
The viral arthritis vaccine market is projected to reach $11.09B by 2030, driven by next-gen vaccine platforms, emerging arboviruses, accelerated trials, and preventive immunization.
Read More
The targeted LNPs for extrahepatic delivery market is projected to reach $4.68B by 2030, driven by RNA therapeutics, tissue-specific delivery systems, ligand-directed nanoparticles, and modular nanocarrier platforms.
Read More
The systemic amyloidosis therapeutics market is projected to reach $8.88B by 2030, driven by targeted biologics, gene silencing therapies, monoclonal antibodies, and combination treatment protocols.
Read More
The super generics market is projected to reach $169.76B by 2030, driven by specialty generics, complex formulations, cost-effective therapies, and patient-friendly drug delivery innovations.
Read More
The single-use membrane chromatography systems market is projected to reach $1.96B by 2030, driven by gene and cell therapy growth, flexible purification adoption, and continuous bioprocessing innovations.
Read More
The recombinant vaccines market is projected to reach $28.07B by 2030 at 12.2% CAGR, driven by precision vaccines, emerging disease programs, adult boosters, and advanced recombinant platforms.
Read More